Efficacy and safety of gantenerumab in the treatment of Alzheimer's disease: A meta-analysis of randomized controlled trials

Elsevier, Archives of Gerontology and Geriatrics Plus, Volume 1, Issue 2, June 2024, 100016
Authors: 
Milene Vitória Sampaio Sobral, Victor Gonçalves Soares, Ocilio Ribeiro Gonçalves, Victoria Städler de Abreu, Lucas Cael Azevedo Ramos Bendaham, Brenda Leticia Lopes Batista M.D., Marco Antonnio Rocha dos Santos M.D., MsC

Gantenerumab has garnered considerable attention for its potential to modify the natural course of Alzheimer's disease. However, recent studies have shown mixed results for the use of this medication for the treatment of Alzheimer's Disease. Therefore, this review compared the effects of Gantenerumab with placebo in patients with Alzheimer's disease.

Read for free on ScienceDirect
Show previous page

Special issue

Category:

Articles

Tags:

Global